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Dear editor,
We read carefully the Buetti et  al. [1] post hoc analy-
sis of two open randomized multicenter French studies, 
comparing non-disinfectant dressings with CHG-releas-
ing sponge (December 2006 to May 2008) [2] and with 
CHG-releasing gel (May 2010 to July 2011) [3].
After adjustment for confounders, gel-dress showed 
similar risk for MCRI compared to sponge-dress 
(HR 0.80, 95% CI 0.28–2.31, p = 0.68) and CRBSI 
(HR 1.13, 95% CI 0.34–3.70, p = 0.85), less dress-
ing disruptions (OR 0.72, 95% CI 0.60–0.86, p < 
0.001), and more contact dermatitis (OR 3.60, 95% 
CI 2.51–5.15, p < 0.01). However, gel-dress increased 
the risk of contact dermatitis only if CHG was used 
for skin antisepsis (OR 1.94, 95% CI 1.38–2.71, p < 
0.01).
Alcoholic-CHG was used for skin preparation in 1533 
of gel-dress recipients (72.7%) and only 20 patients with 
sponge-dress (1.3%) [1]. In a recently published real-
world evidence study, the gel-dress was applied with 
CHG for skin antisepsis [4]. Initial rates of contact der-
matitis were consistent with previous findings [3]. Fol-
lowing the implementation of a redesigned dressing in 
March 2012, contact dermatitis rates dropped from 5.5 
episodes/1000 device-days to 0.3/1000 device-days and 
same levels were reported for both sponge- and the gel-
dress [4].
Several factors may have played a role in this improve-
ment. Firstly, re-designed adhesive distribution in the 
dressing resulted in an improved skin moisture evapo-
ration through the transparent membrane. Secondly, 
two-step skin preparation (scrubbing) were never incor-
porated in our guidelines for skin antisepsis with CHG. 
Thirdly, time allowed for the disinfecting solution to fully 
evaporate was part of our guidelines at time of intro-
duction of CHG dressings in 2007. This practice may 
decrease initial moisture build-up on the skin surface.
Above-mentioned conclusion on increased risk for skin 
irritation is highly concerning as it may challenge major 
elements from widely recommended bundle to prevent 
CRBSI. Alcoholic solutions of CHG have demonstrated 
superior efficacy in prevention of infections complica-
tions and graded IA by CDC Guidelines [5]. Supported 
by two randomized studies [1, 2] and confirmed by a 
real-world study [4], the use of CHG-dressings to reduce 
CRBSI is also a IA scored recommendation [5].
Accordingly, we congratulate Buetti et al. for their out-
standing methodological skills applied in their post hoc 
analysis, but it is of crucial importance to challenge some 
of the conclusions. We urge the medical community not 
to discard either the use of chlorhexidine-dressings and/
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